• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长期持续性非卧床腹膜透析的生存率及死亡风险因素分析:墨西哥一家中心的12年经验

Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center.

作者信息

Cueto-Manzano A M, Quintana-Piña E, Correa-Rotter R

机构信息

Unidad de Investigación Médica en Epidemiología Clinica, Hospital de Especialidades, CMNO, IMSS, Guadalajara, Jalisco, Mexico.

出版信息

Perit Dial Int. 2001 Mar-Apr;21(2):148-53.

PMID:11330558
Abstract

OBJECTIVE

To evaluate patient and technique survival, and to analyze mortality risk factors in a large Mexican single-center continuous ambulatory peritoneal dialysis (CAPD) program.

DESIGN

Cohort study.

SETTING

Tertiary care, teaching hospital located in Mexico City.

PATIENTS

All patients from our CAPD program (1985-1997) were retrospectively studied.

INTERVENTIONS

Clinical and biochemical variables at the start of dialysis were recorded and considered in the analysis of risk factors.

MAIN OUTCOME MEASURES

End points were patient (alive, dead, or lost to follow-up) and technique status at the end of the study (December 1997).

RESULTS

627 patients, 37% with diabetes mellitus (DM), were included. Median patient survival (+/- SE) was 5.1 +/- 0.6 years. In the univariate analysis, the following variables were associated (p < 0.05) with mortality: DM, old age, hypoalbuminemia, low serum creatinine, low serum phosphate, and lymphopenia. In the multivariate analysis, the only significant mortality risk factors were DM (RR 2.56, p < 0.0001), old age (RR 1.01, p = 0.01), hypoalbuminemia (RR 0.77, p = 0.04), and lymphopenia (RR 0.98, p = 0.05). Median technique survival was 4.0 +/- 0.2 years. Peritonitis, hypoalbuminemia, lymphopenia, old age, and DM were all significantly associated (p < 0.05) with technique failure in the univariate analysis, while in the multivariate analysis, only DM (RR 1.78, p = 0.001), peritonitis (RR 1.13, p = 0.004), lymphopenia (0.98, p = 0.04), and hypoalbuminemia (RR 0.80, p = 0.06) were technique failure predictors.

CONCLUSIONS

Patient survival in our setting is similar to that reported in other series. Diabetes mellitus, lymphopenia, and hypoalbuminemia were the strongest predictive factors for mortality and technique failure on CAPD. Our 12-year CAPD program is one of the largest single-centers reported in CAPD literature.

摘要

目的

评估患者生存率和技术生存率,并分析墨西哥一个大型单中心持续性非卧床腹膜透析(CAPD)项目中的死亡风险因素。

设计

队列研究。

地点

位于墨西哥城的三级护理教学医院。

患者

对我们CAPD项目(1985 - 1997年)的所有患者进行回顾性研究。

干预措施

记录透析开始时的临床和生化变量,并在风险因素分析中予以考虑。

主要观察指标

终点为研究结束时(1997年12月)的患者状态(存活、死亡或失访)和技术状态。

结果

纳入627例患者,其中37%患有糖尿病(DM)。患者中位生存时间(±标准误)为5.1±0.6年。单因素分析中,以下变量与死亡率相关(p<0.05):糖尿病、老年、低白蛋白血症、低血清肌酐、低血清磷酸盐和淋巴细胞减少。多因素分析中,唯一显著的死亡风险因素为糖尿病(相对危险度RR 2.56,p<0.0001)、老年(RR 1.01,p = 0.01)、低白蛋白血症(RR 0.77,p = 0.04)和淋巴细胞减少(RR 0.98,p = 0.05)。技术中位生存时间为4.0±0.2年。单因素分析中,腹膜炎、低白蛋白血症、淋巴细胞减少、老年和糖尿病均与技术失败显著相关(p<

相似文献

1
Long-term CAPD survival and analysis of mortality risk factors: 12-year experience of a single Mexican center.长期持续性非卧床腹膜透析的生存率及死亡风险因素分析:墨西哥一家中心的12年经验
Perit Dial Int. 2001 Mar-Apr;21(2):148-53.
2
Patient and technique survival in continuous ambulatory peritoneal dialysis in a single center of the west of Mexico.墨西哥西部单一中心持续性非卧床腹膜透析患者及技术生存率
Rev Invest Clin. 2007 May-Jun;59(3):184-91.
3
Improved patient/technique survival and peritonitis rates in patients treated with automated peritoneal dialysis when compared to continuous ambulatory peritoneal dialysis in a Mexican PD center.在墨西哥一家腹膜透析中心,与持续性非卧床腹膜透析相比,接受自动化腹膜透析治疗的患者其患者/技术生存率及腹膜炎发生率得到改善。
Kidney Int Suppl. 2008 Apr(108):S76-80. doi: 10.1038/sj.ki.5002606.
4
Is high peritoneal transport rate an independent risk factor for CAPD mortality?高腹膜转运率是持续性非卧床腹膜透析(CAPD)患者死亡的独立危险因素吗?
Kidney Int. 2000 Jan;57(1):314-20. doi: 10.1046/j.1523-1755.2000.00817.x.
5
Predictors of patient survival in continuous ambulatory peritoneal dialysis: 10-year experience in 2 major centers in Tehran.持续性非卧床腹膜透析患者生存的预测因素:德黑兰两大中心的10年经验
Iran J Kidney Dis. 2010 Jan;4(1):44-9.
6
Clinical outcomes in elderly patients on chronic peritoneal dialysis: a retrospective study from a single center in china.老年慢性腹膜透析患者的临床结局:来自中国单中心的一项回顾性研究
Perit Dial Int. 2014 May;34(3):299-307. doi: 10.3747/pdi.2012.00209. Epub 2013 Dec 1.
7
Death risk in CAPD patients. The predictive value of the initial clinical and laboratory variables.腹膜透析患者的死亡风险。初始临床和实验室变量的预测价值。
Nephron. 1993;65(1):23-7. doi: 10.1159/000187435.
8
Technique failure in peritoneal dialysis and its impact on patient survival.腹膜透析技术失败及其对患者生存的影响。
Perit Dial Int. 1997 Jul-Aug;17(4):360-4.
9
Relationship between uric acid and technique failure in patients on continuous ambulatory peritoneal dialysis: a long-term observational cohort study.尿酸与持续性不卧床腹膜透析患者技术失败的关系:一项长期观察性队列研究。
BMJ Open. 2017 Apr 7;7(4):e010816. doi: 10.1136/bmjopen-2015-010816.
10
Outcome and risk factors for mortality in pediatric peritoneal dialysis.儿科腹膜透析患者的预后和死亡风险因素。
Perit Dial Int. 2010 Mar-Apr;30(2):233-9. doi: 10.3747/pdi.2008.00278. Epub 2010 Feb 11.

引用本文的文献

1
Assessing biomarker trajectories for mortality risk in peritoneal dialysis: A focus on multivariate joint modeling.评估腹膜透析患者死亡风险的生物标志物轨迹:聚焦多变量联合建模。
PLoS One. 2025 Jul 28;20(7):e0320385. doi: 10.1371/journal.pone.0320385. eCollection 2025.
2
Relationship between glucose to lymphocyte ratio and the first peritonitis episode in patients treated with peritoneal dialysis.接受腹膜透析治疗的患者中葡萄糖与淋巴细胞比值与首次腹膜炎发作之间的关系。
Sci Rep. 2025 Feb 26;15(1):6834. doi: 10.1038/s41598-025-91252-0.
3
Ten-Year Single-Center Study Examining Patient Survival after Commencing Long-Term Peritoneal Dialysis.
一项为期十年的单中心研究:考察开始长期腹膜透析后的患者生存率
J Clin Med. 2023 Nov 24;12(23):7283. doi: 10.3390/jcm12237283.
4
Decreased Peripheral Blood Lymphocyte Count Predicts Poor Treatment Response in Peritoneal Dialysis-Associated Peritonitis.外周血淋巴细胞计数降低预示腹膜透析相关性腹膜炎治疗反应不佳。
J Inflamm Res. 2023 Nov 16;16:5327-5338. doi: 10.2147/JIR.S438674. eCollection 2023.
5
High body mass index is a risk factor for transition to hemodialysis or hybrid therapy and peritoneal dialysis-related infection in Japanese patients undergoing peritoneal dialysis.高身体质量指数是日本腹膜透析患者向血液透析或混合治疗以及腹膜透析相关感染过渡的一个风险因素。
Int Urol Nephrol. 2022 Dec;54(12):3193-3202. doi: 10.1007/s11255-022-03252-y. Epub 2022 Jun 27.
6
Serum Albumin at Start of Peritoneal Dialysis Predicts Long-Term Outcomes in Anhui Han Patients on Continuous Ambulatory Peritoneal Dialysis: A Retrospective Cohort Study.腹膜透析开始时的血清白蛋白可预测安徽汉族持续性非卧床腹膜透析患者的长期预后:一项回顾性队列研究
Kidney Dis (Basel). 2018 Nov;4(4):262-268. doi: 10.1159/000492426. Epub 2018 Sep 3.
7
Comparison of outcomes between emergent-start and planned-start peritoneal dialysis in incident ESRD patients: a prospective observational study.新发终末期肾病患者中紧急开始与计划开始腹膜透析的结局比较:一项前瞻性观察研究。
BMC Nephrol. 2017 Dec 11;18(1):359. doi: 10.1186/s12882-017-0764-6.
8
Trajectories of Serum Albumin Predict Survival of Peritoneal Dialysis Patients: A 15-year Follow-Up Study.血清白蛋白轨迹预测腹膜透析患者的生存率:一项15年随访研究
Medicine (Baltimore). 2016 Mar;95(12):e3202. doi: 10.1097/MD.0000000000003202.
9
Clinical outcomes and mortality in elderly peritoneal dialysis patients.老年腹膜透析患者的临床结局与死亡率
Clinics (Sao Paulo). 2015 May;70(5):363-8. doi: 10.6061/clinics/2015(05)10. Epub 2015 May 1.
10
Risk factors for mortality in Chinese patients on continuous ambulatory peritoneal dialysis.中国持续性非卧床腹膜透析患者死亡的危险因素
Perit Dial Int. 2015 Mar-Apr;35(2):199-205. doi: 10.3747/pdi.2013.00164. Epub 2014 Sep 2.